Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
R. Matsunuma, Y. Ohkuni, A. Komatsu, K. Nakashima, N. Asai, H. Makino, N. Kaneko (Kamogawa-city, Japan). Study of the lung cancer patients on hemodialysis (HD) in Japan. Eur Respir J 2011; 38: Suppl. 55, 2771

Member's Comments

No comment yet.

Related content which might interest you: Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 The role of radiotherapy (RTH) in long-term survival limited disease (LD) small cell lung cancer (SCLC) patients (pts) treated in the National TB and Lung Diseases Research Institute Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002 Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care. Source: International Congress 2019 – Treatment of lung cancer Year: 2019 A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery Year: 2015 Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Use of erlotinib in management of advanced non-small cell lung cancer (NSCLC): The Czech Republic experience with the treatment of a non-selected population of 1735 patients (pts) Source: Annual Congress 2011 - Treatment of lung cancer Year: 2011 Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC). Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Is the lung cancer in elderly similar to lung cancer in younger patients? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Lung cancer screening in COPD patients. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Use of Bode index (BI) in patients with COPD undergoing inpatient pulmonary rehabilitation (IPR) after lung resection (LR) for non small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006 A multicenter phase II study of carboplatin/vinorelbine in advanced non-small cell lung cancer (NSCLC) in elderly patients (GFPC 9902) Source: Eur Respir J 2003; 22: Suppl. 45, 30s Year: 2003 Lower rate of COPD exacerbations in patients with COPD and concurrent lung carcinoma – Data from the Bergmannsheil cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Safety analysis of anti-VEGF therapy bevacizumab (Bv) in patients (pts) with untreated advanced non-small cell lung cancer (NSCLC) in MO19390 (SAiL) trial Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Survival in patients with lung cancer, with and without self reported cardiovascular disease the HUNT study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC) Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Chemotherapy in elderly patients with non-small-cell lung cancer in Tunisian respiratory department Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 A multicenter phase II study of docetaxel (D) weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts): preliminary results of the 0202 GFPC study Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005